FDA may ditch some TV ad requirements

Share this article:

The FDA is rethinking just how many side effects need to be talked about in television ads.

The LA Times reports that the regulator is surveying 1,500 participants to see just how much information they take in and understand when watching advertisements.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.